CD8A and neoplasm: Treatment withintratumoral GLA-SE as an adjuvant to surgery and radiotherapy demonstrated safety and feasibility in Merkle cell carcinoma with increased intratumoral infiltration of CD8+ and CD4+ T cells, activation of immune-related genes, and local tumor regression (193).